Dinesh Kumar Chellappan
Overview
Explore the profile of Dinesh Kumar Chellappan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
290
Citations
2585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Madheswaran T, Chellappan D, Lye F, Dua K
Expert Opin Drug Deliv
. 2025 Mar;
:1-13.
PMID: 40022612
Introduction: Non-small cell lung cancer (NSCLC) continues to pose a considerable health challenge with few therapeutic alternatives. Liquid crystalline nanoparticles (LCN) are nanostructured drug delivery systems made of lipid-based amphiphilic...
2.
Bashir B, Gulati M, Vishwas S, Gupta G, Dhanasekaran M, Paudel K, et al.
Ageing Res Rev
. 2025 Feb;
105:102689.
PMID: 39952328
Aging is an extremely significant risk associated with neurodegeneration. The most prevalent neurodegenerative disorders (NDs), such as Alzheimer's disease (AD) are distinguished by the prevalence of proteinopathy, aberrant glial cell...
3.
Kumbhar P, Kamble V, Kolekar K, Vishwas S, Kumbhar P, Patil K, et al.
Drug Dev Res
. 2025 Feb;
86(1):e70057.
PMID: 39925109
Acne is a skin disease that impacts 9.4% of the world's population. Available treatments for managing acne include retinoid-like drugs, antibiotics, corticosteroids, photo, and radiotherapy. Howevere, the aforementioned treatments have...
4.
Hussain M, Mujwar S, Babu M, Goyal K, Chellappan D, Negi P, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Jan;
PMID: 39862263
As a promising candidate for tackling drug-resistant cancers, triptolide, a diterpenoid derived from the Chinese medicinal plant Tripterygium wilfordii, has been developed. This review summarizes potential antitumor activities, including the...
5.
Krishnakumar A, Chellappan D, Jeyakodi S, Dalal M, Shetty S
Am J Transl Res
. 2025 Jan;
16(12):8043-8053.
PMID: 39822556
Objectives: The concept of beauty from within is a growing trend in the market and people now look for oral supplements that can enhance the well-being of skin from within....
6.
Nasereddin L, Alnajjar O, Bashar H, Abuarab S, Al-Adwan R, Chellappan D, et al.
Diseases
. 2024 Dec;
12(12).
PMID: 39727630
Corticosteroids are extensively used in medicine for their powerful anti-inflammatory and immunosuppressive effects. However, their psychiatric side effects-such as mood disturbances, anxiety, and psychosis-are significant yet often underappreciated. This review...
7.
Haysom-McDowell A, Paudel K, Yeung S, Kokkinis S, El Sherkawi T, Chellappan D, et al.
Mol Oncol
. 2024 Nov;
19(1):15-36.
PMID: 39592417
Lung cancer is the leading cause of cancer death globally, with non-small cell lung cancer accounting for the majority (85%) of cases. Standard treatments including chemotherapy and radiotherapy present multiple...
8.
Corrie L, Singh H, Gulati M, Vishwas S, Chellappan D, Gupta G, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Nov;
398(1):1031-1032.
PMID: 39565398
No abstract available.
9.
Bhardwaj B, Vihal S, Pahwa R, Agarwal S, Gupta B, Yang J, et al.
Carbohydr Polym
. 2024 Nov;
348(Pt A):122809.
PMID: 39562084
Non-toxic, biocompatible, biodegradable, and bioadhesive, characteristics, of natural polysaccharides, are widely recognized and well accepted. Their usage in dietary, medicinal, biomedical, and cosmetic, applications is due to their unique and...
10.
Rohilla S, Awasthi R, Rohilla A, Singh S, Chellappan D, Dua K, et al.
ADMET DMPK
. 2024 Oct;
12(4):657-677.
PMID: 39473624
Background And Purpose: This study aimed to improve the stability and prolonged gefitinib release from the nanoliposomes. Experimental Approach: Nanoliposomes were prepared by reverse-phase evaporation and optimized using Box-Behnken design...